广告
化学
5-HT6受体
药理学
体内
对抗
结构-活动关系
受体
铅化合物
药品
立体化学
体外
5-羟色胺受体
血清素
生物化学
生物
生物技术
作者
Michał Gałęzowski,Charles-Henry Fabritius,Ullamari Pesonen,Harri M. Salo,Marta Olszak-Płachta,Klaudia Czerwińska,Justyna Adamczyk,Marcin Król,Peteris Prūsis,Magdalena Sieprawska-Lupa,Maciej Mikulski,Katja Kuokkanen,Radosław Obuchowicz,Timo Korjamo,Niina Jalava,Agnieszka Nikiforuk,Mateusz Nowak
标识
DOI:10.1016/j.bmcl.2023.129497
摘要
In this study, we present the discovery and pharmacological characterization of a new series of 6-piperazinyl-7-azaindoles. These compounds demonstrate potent antagonism and selectivity against the 5-HT6 receptor. Our research primarily focuses on optimizing the lead structure and investigating the structure–activity relationship (SAR) of these compounds. Our main objective is to improve their activity and selectivity against off-target receptors. Overall, our findings contribute to the advancement of novel compounds targeting the 5-HT6 receptor. Compound 29 exhibits significant promise in terms of pharmacological, physicochemical, and ADME (Absorption, Distribution, Metabolism, and Excretion) properties. Consequently, it merits thorough exploration as a potential drug candidate due to its favorable activity profile and successful outcomes in a range of in vivo experiments.
科研通智能强力驱动
Strongly Powered by AbleSci AI